Behcet's disease: treatment and visual prognosis
SJO-Saudi Journal of Ophthalmology. 1992; 6 (3): 135-40
Dans Anglais
| IMEMR
| ID: emr-26329
ABSTRACT
We carried out a controlled study to compare the effect of the immunosuppressant drug chlorambucil with that of corticosteroids on the ocular type of Behcet's disease. Of our 26 patients, 20 were male and 6 female; all except 9 had suffered from previous episodes and had received systemic steroid therapy at those times. Follow-up varied from 8 to 48 months [average 2 ' years]. Chlorambucil treatment was found to induce remission in 11 of the 13 patients in that group, in two of these for 4 years; this drug was thus found to be effective in about 85% of cases, considerably reducing the intensity of the ocular inflammation and often producing long periods of remission. Steroid treatment alone, on the other hand, was found to be initially effective in about 54% of cases, about half of the eyes in this group suffering repeated exacerbations under maintenance therapy. In the long term, however, visual acuity had decreased about equally in both groups, and the visual prognosis remains poor regardless of the type of therapy despite intensive treatment, loss of useful vision had occurred in 78.6% of all eyes that were followed for 3 to 4 years after initial diagnosis
Recherche sur Google
Indice:
Méditerranée orientale
Sujet Principal:
Uvéite
/
Cataracte
/
Iridocyclite
/
Hormones corticosurrénaliennes
Limites du sujet:
Femelle
/
Humains
/
Mâle
langue:
Anglais
Texte intégral:
Saudi J. Ophthalmol.
Année:
1992
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS